Live News

Journals & Papers, Articles
The Lancet Respiratory Medicine 柳叶刀呼吸医学杂志
[Articles] Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
IntroductionIt is estimated that 3·8 billion people worldwide have been infected with the SARS-CoV-2 virus, which causes C...
[Comment] COVID-19: ACT trials for colchicine and antithrombotic therapies
The COVID-19 pandemic destabilised health-care systems and led to millions of excess deaths worldwide.1COVID-19 Excess Mor...
[Corrections] Correction to Lancet Respir Med 2022; published online July 27. https://doi.org/10.1016/S2213-2600(22)00185-0
PAL is not only present in severe disease, but also in a considerable proportion of patients with milder disease. In patie...
[Correspondence] Standardising corticosteroid use in acute respiratory distress syndrome
The acute respiratory distress syndrome (ARDS) is a common critical illness syndrome with high morbidity and mortality. Th...
[Spotlight] Opioid use and sleep apnoea
Opioid prescriptions in the USA have fallen over the past decade or so. But the numbers are still enormous. In 2020, US ph...
[Corrections] Correction to Lancet Respir Med 2022; 10: 700–14
Unique challenges arise when conducting trials to evaluate therapies already in common clinical use, including difficulty ...
[Comment] Moving the pathway goalposts: COPD as an immune-mediated inflammatory disease
Chronic obstructive pulmonary disease (COPD) encompasses a spectrum of lung disorders that cause lung function decli...